A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05673109 · TERMINATED
Trial details
- NCT number
- NCT05673109
- Sponsor
- Accutar Biotechnology Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2023-10-08
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.